Fact CheckerSign in

NCT06728644Completed

The Role of L-arginine in Polycystic Ovary Syndrome

The Safety and Efficacy of L-arginine in Patients With Polycystic Ovary Syndrome

Source: ClinicalTrials.gov · Last updated 11 Jul 2025

Brief summary (registry, in English)

PCOS patients meeting the trial criteria were enrolled from the Shanghai 10th People's Hospital. The contents of this study were introduced to them, and they were invited to participate in the study. We further evaluated the efficacy and safety of arginine in treating PCOS by implementing the L-arginine clinical intervention protocol, and conducting post-intervention follow-up, efficacy evaluation, laboratory tests, and fecal sample 16S rRNA sequencing.

Status (registry)
Completed
Study type
Interventional
Enrollment
31 (actual)
First submitted
8 Dec 2024
Start date
14 Jul 2024
Primary completion date
4 Jul 2025
Lead sponsor
Shanghai 10th People's Hospital
NCT number
NCT06728644

What you commit to

  • Study type: Interventional
  • Participants enrolled: 31
  • From 14 Jul 2024 to the primary completion date, 4 Jul 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cancer patients;
  • Associated with severe infection, severe anemia, neutropenia and other blood system diseases;
  • Have type 1 diabetes, single-gene mutated diabetes or other secondary diabetes;
  • Patients with mental illness or intellectual disability;
  • Have a long history of taking hormone therapy;

Other

  • Pregnant women;
  • Hyperthyroidism or hypothyroidism
  • Severe liver and kidney function injury
  • Currently or recently participating in another clinical trial.

Who the study is looking for

  • aged 18-45 years
  • Diagnosis of PCOS with the Rotterdam diagnosis criteria (2003)

Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shanghai Tenth People's Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status
Department of Endocrinology, Shanghai Tenth People's Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.